Results for
""Zoledronic Acid""[mesh_terms]

Bisphosphonate-loaded bone cement: Background, clinical indications and future perspectives.

Panteleimon N Zogakis, Alisson R Teles, Εvangelos P Zafeiris, Christos P Zafeiris

Journal of musculoskeletal & neuronal interactions 2022;22(4):587-595

Quantification of Low Amounts of Zoledronic Acid by HPLC-ESI-MS Analysis: Method Development and Validation.

Anca-Roxana Petrovici, Mihaela Silion, Natalia Simionescu, Rami Kallala, Mariana Pinteala, Stelian S Maier

International journal of molecular sciences 2022;23(11):5944

Treatment of Hypercalcemia of Malignancy.

Ghada El-Hajj Fuleihan, Marlene Chakhtoura

Endocrinology and metabolism clinics of North America 2022;50(4):781-792

Zoledronic acid in the treatment of hypercalcemia of malignancy: results of the international clinical development program.

R E Coleman, P P Major

Seminars in oncology 2001;28(2 Suppl 6):17-24

Safety and Efficacy of Zoledronic Acid Treatment with and without Acetaminophen and Eldecalcitol for Osteoporosis.

Takeshi Mochizuki, Koichiro Yano, Katsunori Ikari, Ken Okazaki

Internal medicine (Tokyo, Japan) 2021;60(16):2585-2591

Relationship Between Changes in Serum Levels of Intact Parathyroid Hormone and Sclerostin After a Single Dose of Zoledronic Acid: Results of a Phase 1 Pharmacokinetic Study.

Satoshi Tanaka, Tatsuhiko Kuroda, Masataka Shiraki, Toshitaka Nakamura, Hiroaki Suzuki, Kazuki Hiraishi, Toshitsugu Sugimoto

Calcified tissue international 2022;110(1):87-92

Combination of Calcitriol and Zoledronic Acid on PINP and -CTX in Postoperative Patients with Diabetic Osteoporosis: A Randomized Controlled Trial.

Guangdong Chen, Lei Zhang, Lishuai Yao, Fan Liu, Qi Wang, Qingchang Hu

Disease markers 2022;2022():6053410

Patient and Physician Decisional Factors Regarding Hypercalcemia of Malignancy Treatment: A Novel Mixed-Methods Study.

Matthew T Drake, Maya Rahme, Ghada El-Hajj Fuleihan, Thomas Piggott, Mohammad H Murad, Aya Bassatne

The Journal of clinical endocrinology and metabolism 2023;108(3):563-584

Adverse events associated with bone-directed therapies in patients with cancer.

Mark A Jara, Jeena Varghese, Mimi I Hu

Bone 2022;158():115901

Dosimetry of Bone Seeking Beta Emitters for Bone Pain Palliation Metastases.

I Murray, K Liepe, G Flux

Seminars in nuclear medicine 2022;52(2):178-190

Advances in the biology and treatment of myeloma bone disease.

J R Berenson

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2002;58 Suppl 3():S16-20

Safety of Inpatient Zoledronic Acid in the Immediate Postfracture Setting.

WuQiang Fan, Benjamin Z Leder, Michael Mannstadt, Thuan V Ly, Esteban Franco-Garcia, Marcy B Bolster

The Journal of clinical endocrinology and metabolism 2023;108(11):e1282-e1288

Drug-Inclusive Inorganic-Organic Hybrid Systems for the Controlled Release of the Osteoporosis Drug Zoledronate.

Maria Vassaki, Savvina Lazarou, Petri Turhanen, Duane Choquesillo-Lazarte, Konstantinos D Demadis

Molecules (Basel, Switzerland) 2022;27(19):6212

Protocol for a pilot randomised controlled trial of zoledronic acid to prevent bone loss following sleeve gastrectomy surgery.

Laura E Flores, Lynn Mack, Christopher Wichman, Ashley A Weaver, Vishal Kothari, Laura D Bilek

BMJ open 2022;11(12):e057483